ENDRA Life Sciences (NDRA) Consolidated Net Income (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Consolidated Net Income of -$1.3 million for Q1 2026, down 26.55% year-over-year from -$1.8 million in Q1 2025, and up 58.62% quarter-over-quarter from -$3.2 million in Q4 2025.
ENDRA Life Sciences (NDRA) Consolidated Net Income (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Consolidated Net Income data on file, last reported at -$1.3 million in Q1 2026.
- Consolidated Net Income for Q1 2026 came in at -$1.3 million, down 26.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.3 million (up 25.24% YoY), and the FY2025 annual result was -$7.0 million, up 38.93% from the prior year.
- Consolidated Net Income advanced to -$1.3 million in Q1 2026 per NDRA's latest filing, from -$3.2 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$1.0 million in Q1 2025 and troughed at -$4.1 million in Q4 2024.
- A 5-year average of -$2.5 million and a median of -$2.8 million in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income tumbled 184.27% in 2024, then jumped 62.66% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$3.3 million in 2022, then surged by 55.63% to -$1.5 million in 2023, then plunged by 184.27% to -$4.1 million in 2024, then increased by 23.62% to -$3.2 million in 2025, then soared by 58.62% to -$1.3 million in 2026.
- Business Quant data shows NDRA's Consolidated Net Income at -$1.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.31 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -4.15 Mn |
| Sep 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.23 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.56 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -3.29 Mn |
| Sep 30, 2022 | -3.44 Mn |
| Jun 30, 2022 | -3.59 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.10 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | -3.20 Mn |